View in EDS HTML Full Text PDF Full Text

Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial.
Authors: Muñoz-Rivas, Nuria1,2 (AUTHOR) nmunozr@salud.madrid.org, Aibar, Jesús3,4 (AUTHOR), Gabara-Xancó, Cristina3,4 (AUTHOR), Trueba-Vicente, Ángela5 (AUTHOR), Urbelz-Pérez, Ana5 (AUTHOR), Gómez-Del Olmo, Vicente6 (AUTHOR), Demelo-Rodríguez, Pablo7 (AUTHOR), Rivera-Gallego, Alberto8 (AUTHOR), Bosch-Nicolau, Pau9 (AUTHOR), Perez-Pinar, Montserrat10 (AUTHOR), Rios-Prego, Mónica11 (AUTHOR), Madridano-Cobo, Olga12 (AUTHOR), Ramos-Alonso, Laura13 (AUTHOR), Alonso-Carrillo, Jesús14 (AUTHOR), Francisco-Albelsa, Iria15 (AUTHOR), Martí-Saez, Edelmira16 (AUTHOR), Maestre-Peiró, Ana17 (AUTHOR), Méndez-Bailón, Manuel2,18 (AUTHOR), Hernández-Rivas, José Ángel2,19 (AUTHOR) nmunozr@salud.madrid.org, Torres-Macho, Juan1,2 (AUTHOR)
Source: Journal of Clinical Medicine. Oct2022, Vol. 11 Issue 19, p5632. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20770383
DOI:10.3390/jcm11195632